Target Name: USP17L25
NCBI ID: G728373
Review Report on USP17L25 Target / Biomarker Content of Review Report on USP17L25 Target / Biomarker
USP17L25
Other Name(s): LOC728373 | LOC728400 | LOC728379 | LOC728419 | similar to deubiquitinating enzyme 3 | ubiquitin specific peptidase 17 like family member 25 | Deubiquitinating enzyme 17 | LOC728393 | Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 | Ubiquitin specific peptidase 17 like family member 25 | Ubiquitin-specific-processing protease 17 | LOC728369 | Ubiquitin thioesterase 17 | LOC728405 | U17LO_HUMAN

USP17L25: A Potential Drug Target and Biomarker

USP17L25 is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the USP family of proteins, which are known for their role in cell signaling and modulation of gene expression. USP17L25 has been identified as a potential drug target and biomarker for various diseases, including cancer, diabetes, and neurodegenerative disorders.

Potential Drug Target

The USP family of proteins plays a crucial role in cell signaling and modulation of gene expression. USP17L25 is involved in various signaling pathways, including the TGF-β pathway, which is involved in cell growth, differentiation, and survival. This pathway is often targeted by drugs that are used to treat cancer, neurodegenerative disorders, and other diseases.

One of the key functions of USP17L25 is its role in the TGF-β pathway. This pathway is involved in the regulation of cell growth and differentiation, and is often disrupted in various diseases. USP17L25 has been shown to play a positive role in the regulation of TGF-β signaling, which may make it an attractive target for drugs that are used to treat these diseases.

Potential Biomarker

USP17L25 has also been identified as a potential biomarker for various diseases. Its expression has been shown in a variety of tissues, including the brain, pancreas, and gastrointestinal tract. This suggests that it may be a useful biomarker for diseases that affect these tissues, such as cancer, neurodegenerative disorders, and diabetes.

In addition, USP17L25 has been shown to be involved in the regulation of various signaling pathways, including the TGF-β pathway. This suggests that it may be a useful biomarker for diseases that are caused by disruptions in this pathway, such as cancer and neurodegenerative disorders.

Conclusion

In conclusion, USP17L25 is a protein that is expressed in various tissues of the body and is involved in various signaling pathways. Its expression has been shown in diseases that affect these tissues, including cancer, neurodegenerative disorders, and diabetes. This suggests that it may be a useful drug target and biomarker for these diseases. Further research is needed to determine the full role of USP17L25 in these diseases and to develop safe and effective treatments.

Protein Name: Ubiquitin Specific Peptidase 17 Like Family Member 25

Functions: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection

The "USP17L25 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP17L25 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase | VAMP1 | VAMP2 | VAMP3 | VAMP4 | VAMP5 | VAMP7 | VAMP8 | VANGL1 | VANGL2 | VAPA